Context Therapeutics (NASDAQ:CNTX) Issues Earnings Results
Context Therapeutics (NASDAQ:CNTX – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.04), FiscalAI reports. Context Therapeutics Price Performance Shares of NASDAQ:CNTX traded up $0.14 during mid-day trading on Monday, hitting $3.02. The company had [...]